Deletion of the DNA-binding domain of the transcription factor Ikaros generates dominant-negative isoforms that interfere with its activity and correlate with poor prognosis in human precursor B cell acute lymphoblastic leukemia (B-ALL). Here we found that conditional inactivation of the Ikaros DNA-binding domain in early pre-B cells arrested their differentiation at a stage at which integrin-dependent adhesion to niches augmented signaling via mitogen-activated protein kinases, proliferation and self-renewal and attenuated signaling via the pre-B cell signaling complex (pre-BCR) and the differentiation of pre-B cells. Transplantation of polyclonal Ikaros-mutant pre-B cells resulted in long-latency oligoclonal pre-B-ALL, which demonstrates that loss of Ikaros contributes to multistep B cell leukemogenesis. Our results explain how normal pre-B cells transit from a highly proliferative and stroma-dependent phase to a stroma-independent phase during which differentiation is enabled, and suggest potential therapeutic strategies for Ikaros-mutant B-ALL.
B cell differentiation is characterized by stage-specific expression of cell-surface markers and recombination of genes encoding the immunoglobulin heavy chain (Igh) and light chain (Igk or Igl). Those events are responsible for the generation of a large pool of immature B cells from which selection based on antigen-receptor specificity takes place 1, 2 . Productive rearrangements at the Igh locus allow pairing of the expressed immunoglobulin M (IgM) with the surrogate light chains VpreB (CD179a) and λ5 (CD179b) and the proximal signaling molecules immunoglobulin-α and immunoglobulin-β to form a precursor B cell (pre-B cell) signaling complex (pre-BCR). Subsequent engagement of the tyrosine kinases Lyn, Fyn, Blk and Syk activates signaling cascades that support the proliferative expansion and differentiation of pre-B cells 3 . Loss-of-function mutations in genes encoding components of the pre-BCR signaling complex or its associated tyrosine kinases cause arrest at an early B cell-precursor stage [4] [5] [6] [7] [8] [9] [10] . The pre-BCR, working in concert with the growth-promoting cytokine receptor IL-7R, activates phosphatidylinositol-3-OH kinase (PI(3)K) and the kinase Akt (PI(3)K-Akt) and the mitogen-activated protein kinases (MAPKs) Erk1 and Erk2 (Erk1-Erk2) and thereby supports the survival and proliferation of pre-B cells [11] [12] [13] [14] .
Pre-BCR signaling also induces differentiation through a distinct set of signaling effectors, such as Btk, SLP-65 (BLNK) and PLC-γ2 (refs. 15-17) . Those inhibit the PI(3)K pathway while activating Ca 2+ signaling and a network of transcription factors responsible for exit from the cell cycle and rearrangement of the genes encoding immunoglobulin light chains [18] [19] [20] . Although the importance of pre-BCR signaling in proliferation and differentiation is well established, how the transition between those two disparate phases occurs remains unclear. Loss of IL-7R signaling, as well as quantitative and qualitative changes in pre-BCR signaling, have been proposed as possible mechanisms that underlie that pre-B cell switch.
Human precursor B cell acute lymphoblastic leukemia (B-ALL) frequently displays a pre-B cell phenotype, which suggests that a block at the proliferative stage of pre-B cells may contribute to leukemogenesis 21 . Genome-wide studies of human leukemia have identified loss-of-function mutations in genes encoding regulators of B cell differentiation, such as PAX5, TCF3, EBF1 and IKZF1 (which encodes the transcription factor Ikaros), in ~40% of samples from patients with precursor B-ALL 22 . Notably, mutations in IKZF1, including those that result in deletions in the DNA-binding domain of Ikaros, have been singled out as genetic lesions associated with a poor prognosis for B-ALL [23] [24] [25] [26] [27] . Ikaros is needed to induce the transcription of lymphoid-specific genes in multipotent progenitor cells, and loss of Ikaros leads to developmental arrest before specification of the B cell lineage 28, 29 . Ikaros, together with its family member Aiolos, which is induced after B cell lineage specification 30 , have been linked to the promotion of pre-BCR-mediated differentiation by repressing expression of the surrogate light chains of the pre-BCR complex 31 .
Here we provide new insight into how pre-B cells switch from proliferation to differentiation, a process that is vulnerable to leukemic transformation. We describe a stroma-adherent self-renewing stage of pre-B cell differentiation during which cells expressed the pre-BCR signaling complex and showed substantial activation of the Erk1-Erk2 and PI(3)K-Akt proliferation and survival pathways but had none of the Ca 2+ signaling potential normally required for differentiation. Loss of the adhesion of pre-B cells to stroma correlated with attenuation of Erk1-Erk2 and PI(3)K-Akt activity with reduction in proliferation and an increase in the activity of differentiation-inducing components of the pre-BCR signaling complex and the potential for Ca 2+ signaling. Notably, the transition of pre-B cells from a stroma-adherent proliferative phase to a nonadherent differentiation phase was dependent on Ikaros. Loss of Ikaros augmented stromal adhesion in an integrin-dependent manner and locked pre-B cells in the highly proliferative and selfrenewing phase from which B-ALL can arise. Notably, the survival and proliferation of Ikaros-deficient pre-B cells was strictly dependent on cooperation between signaling via integrins and signaling via receptors for growth factors; this suggests a new avenue for the treatment of B-ALLs that result from IKZF1 mutations, which have a poor prognosis.
RESULTS

Differentiation of pre-B cells requires the Ikaros family
To investigate the role of the Ikaros family during B cell differentiation, we generated cells in which exon 5 of Ikzf1 (called 'IkE5' here), which encodes two Ikaros DNA-binding zinc fingers, was flanked with loxP (IkE5 fl/fl ) (Fig. 1a) and was deleted starting from common lymphoid progenitor cells or the downstream definitive precursor of pro-B cells by Cre recombinase expressed via a transgene driven by the gene encoding CD2 (Cd2-Cre) or CD19 (Cd19-Cre), respectively ( Supplementary Fig. 1a) . Deletion of IkE5 generated Ikaros isoforms that lacked DNA-binding activity and were structurally similar to the Ikaros isoform (Ik6) of human B-ALL 24 (Fig. 1b) . Such mutant Ikaros isoforms act in a dominant-negative way by forming dimers with coexpressed family members, including Aiolos, and interfering with their DNA-binding activity 30, 32 . We confirmed the dominant-negative phenotype by combining a homozygous null mutation of Ikzf3 (which encodes Aiolos) with a heterozygous null mutation of Ikzf1 (Ikzf3 −/− Ikzf1 +/− ). Cre-mediated deletion of IkE5 (IkE5 ∆/∆ ) or the combined Ikzf3 −/− Ikzf1 +/− mutations resulted in similar blockade and population expansion of large pre-B cells (CD19 + CD43 + BP1 + cells; Fig. 1c,d and Supplementary Fig. 1b,c) . Those normally represent a minor population but were present in the mutant mice in numbers similar to those A r t i c l e s of all B cells in the bone marrow (BM) of wild-type mice (Fig. 1d) . As in wild-type mice, most mutant large pre-B cells were in the cell cycle (Fig. 1e) . The few immature (CD19 + IgM + ) B cells detected in IkE5 fl/fl Cd2-Cre mice (Fig. 1d) had not undergone deletion of IkE5 (Supplementary Fig. 1d ), which indicated that the transition from large pre-B cell to small pre-B cell was absolutely dependent on the DNA-binding activity of members of the Ikaros family expressed at this stage of differentiation.
A hallmark of B cell differentiation is successful recombination of the Igh locus, a prerequisite for transition to the pre-B cell stage. We detected proximal and distal recombination events at the diversityjoining (D-J) and variable-DJ (V-DJ) regions of the Igh locus at similar frequencies in wild-type and IkE5 ∆/∆ pre-B cells (Fig. 1f and data not shown). However, the few Igk rearrangements detected in wild-type were not present in mutant pre-B cells (Fig. 1f) , which indicated either an inability to undergo light-chain recombination or a block in differentiation before Igk recombination. Consistent with recombination only at the Igh locus, most mutant pre-B cells expressed intracellular IgM but not immunoglobulin κ-chain (Supplementary Fig. 2 ).
Since Igk recombination is required for B cell maturation, we attempted to 'rescue' the pre-B cell arrest by crossing the IkE5 ∆/∆ mice with mice of the D23 line, which transgenically express a pre-rearranged immunoglobulin κ-chain 33 . IkE5 ∆/∆ D23 pre-B cells were unable to differentiate beyond the large pre-B cell (CD19 + CD43 + BP1 + ) stage ( Fig. 1g and Supplementary Fig. 2 ), although both IgM and immunoglobulin κ-chains were expressed intracellularly. This indicated that lack of Igk recombination was not the cause of the maturation defect in Ikaros-deficient pre-B cells. Hence, the transition from large pre-B cell to small pre-B cell was regulated by the Ikaros family through a mechanism that was independent of recombination at the loci encoding the immunoglobulin heavy and light chains.
Growth of IkE5 ∆/∆ pre-B cells requires adhesion to stroma We further evaluated the developmental defect of IkE5 ∆/∆ large pre-B cells cultured in vitro 11, 34 . Under differentiation-inducing conditions (7 d of stroma-free culture in low concentrations of serum and interleukin 7 (IL-7)), most wild-type large pre-B cells exited from the cell cycle and differentiated into small (CD19 + CD2 + IgM − ) pre-B cells and immature (CD19 + IgM + CD2 + ) B cells, whereas mutant large (CD19 + CD43 + BP1 + ) pre-B cells remained undifferentiated (Fig. 2a) . An increase in the concentration of IL-7 promoted the proliferative expansion of wild-type large pre-B cells but had little effect on their mutant counterparts (Fig. 2b) . In the absence of stroma, survival of IkE5 ∆/∆ pre-B cells was greatly compromised compared with that of wild-type pre-B cells, even in the presence of high concentrations of IL-7, with abundant apoptosis detectable from early time points of culture (Fig. 2c) .
Although precursors of pre-B cells can proliferate and differentiate in the absence of stromal contact, they can self-renew and undergo greater population expansion only on stroma [34] [35] [36] . Since IkE5 ∆/∆ large pre-B cells proliferated and expanded their populations in vivo in the BM, we assessed whether they were able to grow in vitro on BMderived OP9 stromal cells. Under those conditions, IkE5 ∆/∆ large pre-B cells grew better than their wild-type counterparts, especially under limiting concentrations of IL-7 (Fig. 2b) , with about two-to tenfold more cells in cycle (Fig. 2d) . IkE5 ∆/∆ pre-B cells also displayed higher cell-cycle kinetics than did their wild-type counterparts (Fig. 2e) . Labeling with the thymidine analog BrdU showed greater incorporation of BrdU during the pulse period and a faster decrease in the proportion of BrdU + cells during the chase period by IkE5 ∆/∆ pre-B cells than by wild-type pre-B cells (Fig. 2e) , which indicated shorter cell-cycle transitions in IkE5 ∆/∆ pre-B cells than in wild-type pre-B cells. IkE5 ∆/∆ pre-B cells were therefore dependent on stroma for survival and growth, with enhanced proliferation and more rapid cell cycling relative to that of wild-type pre-B cells.
Ikaros loss arrests pre-B cells in an adherent phase We noted a striking morphological difference between IkE5 ∆/∆ and wild-type large pre-B cells in OP9 stromal cultures. Most wild-type pre-B cells were round, light-refracting cells loosely attached to stroma, but most mutant cells had a dark, flat morphology and seemed to be incorporated into the stromal layer (Fig. 3a,b) . Dark, stromaadherent pre-B cells were also present in wild-type cultures but at a much lower frequency (Fig. 3a,b) . The few nonadherent IkE5 ∆/∆ cells displayed enhanced apoptosis (Supplementary Fig. 3a) , which indicated that in the absence of contact with stroma, their survival was greatly compromised. 
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A r t i c l e s
We next established a progenitor-progeny relationship between adherent and nonadherent pre-B cells in wild-type cultures.
Comparison of transcriptional profiles revealed that genes encoding small pre-B cell markers (such as Igl, Rag1, Rag2, Irf4, Cd2 and Cd25) that had low expression in adherent pre-B cells were induced in the nonadherent fraction, whereas genes encoding cell cyclepromoting molecules (such as Ccnd2, Egr1, Pcna, Igfbp4 and Myc) displayed the opposite expression pattern (Fig. 3c) . The overall gene expression of adherent mutant pre-B cells was similar to that of their adherent wild-type counterparts, although we noted a further decrease in the expression of genes encoding small pre-B cell markers in the mutant cells (Fig. 3c) . We also detected similar differences between adherent and nonadherent wild-type pre-B cells in their expression of small pre-B cell markers, such as CD25 and intracellular immunoglobulin κ-chain, by flow cytometry (Fig. 3d) . Those wild-type pre-B cell subsets had similar intracellular expression of the immunoglobulin µ-heavy chain, a 'pan pre-B cell' marker (Fig. 3d) . In the mutant cultures, adherent pre-B cells expressed cytoplasmic immunoglobulin µ-heavy chain but no immunoglobulin κ-chain or CD25, consistent with our ex vivo analysis of IkE5 ∆/∆ pre-B cells (Fig. 1f,g ).
We also evaluated the cell-cycle properties of adherent and nonadherent wild-type pre-B cells. Whereas most adherent wild-type pre-B cells were in cycle, nonadherent wild-type pre-B cells consisted of large cycling and smaller noncycling cells at a ratio that decreased over time in culture ( Supplementary Fig. 3b and data not shown). We were able to serially passage adherent wild-type pre-B cells on stroma, and those cells gave rise to both adherent and nonadherent cells, whereas nonadherent wild-type pre-B cells gave rise to mostly nonadherent cells with limited proliferative expansion (Fig. 3e) .
Given the self-renewing potential of adherent pre-B cells, we compared the clonogenic properties of adherent wild-type and mutant pre-B cells in a limiting-dilution colony-forming assay on stroma.
Even in the absence of IL-7, the colony-forming potential of IkE5 ∆/∆ pre-B cells was high (~20%) and was orders of magnitude greater than that of their wild-type counterparts (Fig. 3f) . Although the addition of IL-7 had little effect on the ability of adherent IkE5 ∆/∆ pre-B cells to form colonies on stroma, it did increase their population size by increasing their proliferation ( Fig. 2d and data not shown). Evaluation of the ability of adherent wild-type and IkE5 ∆/∆ pre-B cells to reassociate with the stroma revealed another important difference: within 3 h of replating, 68% of IkE5 ∆/∆ pre-B cells rapidly rebound to the stroma, whereas only 15% of wild-type adherent cells did so, even after overnight incubation (Fig. 3g) .
Together these studies provided insight into pre-B cell differentiation by describing the transition from a stromaadherent phase to a nonadherent phase. Stroma-adherent pre-B cells expressing the pre-BCR were highly proliferative and had limited self-renewing potential. They were highly dependent on Ikaros for the transition to a nonadherent phase, at which time they exited the cell cycle, lost their capacity for self-renewal and acquired the expression of genes encoding molecules that support B cell maturation. Loss of Ikaros augmented adhesion to stroma, self-renewal and proliferation, pathways that probably antagonize activation of the pre-B cell-differentiation program. 
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Ikaros loss augments stroma-dependent proliferation The survival and proliferative expansion of pre-B cells were supported by a combination of signaling via the pre-BCR and IL-7R that activated the PI(3)K-Akt and Erk1-Erk2 MAPK pathways (Fig. 4a,b and Supplementary Fig. 4a ). Both PI(3)K-Akt and Erk1-Erk2 were active in adherent wild-type pre-B cells but not in nonadherent wild-type pre-B cells (Fig. 4a ), which were in the process of exiting from the cell cycle ( Supplementary Fig. 3b ) and upregulating expression of genes encoding small pre-B cell markers (Fig. 3c,d ). Activation of Akt was similar in adherent IkE5 ∆/∆ pre-B cells and their wild-type counterparts, but activation of Erk1 and Erk2 was much greater in the former cells (Fig. 4a) . Consistent with the enhanced MAPK activity of Erk1-Erk2, we observed a greater abundance of cyclin D2 (Fig. 4a ) that correlated with faster transit through the cell cycle (Fig. 2d,e) in IkE5 ∆/∆ large pre-B cells than in wild-type large pre-B cells.
Pre-BCR signaling also supported differentiation into the small pre-B cell stage by activating signaling via PLC-γ and Ca 2+ ( Supplementary Fig. 4a ), which are signaling events required for cells to switch from a proliferative state to a quiescent state by inducing transcriptional responses that rely in part on the transcription factor Foxo1 (refs. 18,20) . Notably, the baseline intracellular concentration of Ca 2+ was low in adherent wild-type and IkE5 ∆/∆ pre-B cells but was higher in nonadherent wild-type pre-B cells, which were the only cells able to flux Ca 2+ after engagement of the pre-BCR or treatment with ionomycin ( Fig. 4c and Supplementary Fig. 4b ). Upstream and downstream effectors of Ca 2+ signaling, such as BLNK and Foxo1, had low expression in adherent wild-type and IkE5 ∆/∆ pre-B cells and were greatly induced in nonadherent wild-type cells (Fig. 4b) , consistent with the differentiation of small pre-B cells. The small amounts of Foxo1 in adherent pre-B cells were phosphorylated (Fig. 4b) , which correlated with active PI(3)K-Akt in these cells. As reported before for the differentiation of small pre-B cells 20 , the MAPK activity of the kinase p38 was induced during the transition of pre-B cells from adherent to nonadherent but was nearly undetectable in adherent IkE5 ∆/∆ pre-B cells (Fig. 4b) .
Both the proliferation-and differentiation-inducing arms of pre-BCR signaling are dependent on activation of Fyn, Lyn, Blk and Syk. Those tyrosine kinases were expressed at similar amounts in adherent and nonadherent wild-type pre-B cells (Fig. 4b) . Adherent IkE5 ∆/∆ pre-B cells had much smaller amounts of those key proximal components of pre-BCR signaling (Fyn, Syk and Blk) than did adherent wild-type pre-B cells, while the amount of activated (phosphorylated) Lyn was also diminished (Fig. 4b and Supplementary Fig. 4c ). The lower protein expression and activation of those tyrosine kinases was unexpected, as it indicated a defect not only in the differentiation of IkE5 ∆/∆ pre-B cells but also in their proliferation, contrary to the results we obtained both in vivo and in vitro ( Figs. 1 and 2) .
We asseed IL-7R signaling as a possible mechanism of compensation for the loss in pre-BCR signaling. Phosphorylation of the transcription factor STAT5, a measure of IL-7R signaling, was similar in adherent wild-type and IkE5 ∆/∆ pre-B cells (Fig. 4a) . Furthermore, and in contrast to results obtained for wild-type pre-B cells, IL-7R signaling was unable to support the growth of mutant pre-B cells under stroma-free conditions, and the mutant pre-B cells were only partly dependent on IL-7 for growth on stroma (Figs. 2b and 3f) . Thus, receptors other than IL-7R and the pre-BCR must have been responsible for the activation of survival and proliferation signaling pathways in IkE5 ∆/∆ large pre-B cells. Engagement of such receptors was probably mediated by the strong interaction of the mutant pre-B cells with the stroma.
Enhanced integrin signaling in IkE5 ∆/∆ pre-B cells We used comparative genome-wide transcriptional analysis of primary and cultured wild-type and IkE5 ∆/∆ pre-B cells to identify potential pathways that might support the aberrant adhesion and growth properties of the mutant population. We deduced a signature of genes with different expression in freshly isolated IkE5 ∆/∆ large pre-B cells versus wild-type large pre-B cells and in adherent IkE5 ∆/∆ pre-B cells versus adherent wild-type pre-B cells cultured in vitro (Fig. 5a,b) . The group of genes upregulated in IkE5 ∆/∆ pre-B cells showed considerable enrichment for those encoding molecules in pathways involved in focal adhesion and remodeling of the actin cytoskeleton (Fig. 5a) . Genes encoding integrins (for example, Itga1, Itga5 and Itgb1), as well as those encoding other structural and signaling components of focal adhesions (for example, Ptk2, Vcl, Actn1, Cttn, Dock1 and Rogdi), were shared by many of those pathways (Fig. 5b) . We confirmed the upregulation of integrin expression at the protein level in both primary and cultured cells (Fig. 5c) Figure 4 Signaling pathways in wild-type and Ikaros-deficient pre-B cells. (a,b) Immunoblot analysis of total and phosphorylated (p-) pre-BCR-affiliated tyrosine kinases and downstream differentiation-inducing signaling effectors (as described in Supplementary Fig. 4a npg A r t i c l e s of integrin signaling was higher in IkE5 ∆/∆ pre-B cells (Fig. 5c-f) .
Although it was not as pronounced as that in IkE5 ∆/∆ pre-B cells, we also observed a much greater abundance of total and phosphorylated FAK in adherent wild-type pre-B cells than in nonadherent wild-type pre-B cells ( Fig. 5d-f) , which indicated that integrin signaling was also active in adherent wild-type pre-B cells.
Further evidence of integrin-mediated adhesion was provided by measurement of the binding of adherent pre-B cells to integrin ligands in vitro. Notably, the frequency with which IkE5 ∆/∆ pre-B cells (~80%) or wild-type pre-B cells (~20%) bound to fibronectin (Fig. 5g) was similar to the frequency with which they bound to stroma (Fig. 3g) . The addition of a fibronectin peptide (RGD) that binds to integrin α 4 β 1 (VLA-4) significantly inhibited the binding of both wild-type and IkE5 ∆/∆ pre-B cells (Fig. 5g) , which indicated that α 4 β 1 was one of the integrins involved in the adhesion of pre-B cells.
Integrin signaling is involved in the chemotaxis of pre-B cells in response to interactions of the chemokine CXCL12 (SDF-1) with its receptor (CXCR4) 37 . We assessed whether the enhanced integrin signaling in IkE5 ∆/∆ pre-B cells affected their chemotactic properties. In contrast to results obtained for adherent wild-type pre-B cells, adherent IkE5 ∆/∆ pre-B cells were unable to migrate in a Transwell assay in response to CXCL12 (Fig. 5h) , which indicated that increased integrin signaling diminished the chemokine-mediated chemotaxis of the mutant pre-B cells. Consistent with those in vitro data, we did not detect circulating pre-B cells in IkE5 fl/fl Cd19-Cre mice, although they were readily detectable in wild-type mice ( Supplementary  Fig. 5a ). Thus, the increase in integrin signaling manifested after loss of Ikaros in pre-B cells was probably responsible for their stable adhesion to stroma, their survival and their proliferative expansion in the BM. (Fig. 6a) . However, the loss of adhesion preceded an increase in apoptosis only in IkE5 ∆/∆ pre-B cells, not in wild-type pre-B cells (Fig. 6b) .
We also assessed the dependence of IkE5 ∆/∆ pre-B cells on integrin signaling in vivo. We gave IkE5 fl/fl Cd19-Cre mice and their wild-type littermates three to five doses of an orally bioavailable inhibitor of FAK and Ptk2b (PF-562271) or vehicle control and quantified BM pre-B cells and B cells and their apoptotic index shortly thereafter (Fig. 6c,d) . IkE5 ∆/∆ large pre-B cells constituted most of the BM B cells in vehicletreated IkE5 fl/fl Cd19-Cre mice, and these cells rapidly decreased in abundance after treatment with the FAK inhibitor (Fig. 6c) . That decrease correlated with an increase in apoptosis that was specific for mutant large pre-B cells and correlated with a decrease in activated (phosphorylated) FAK in IkE5 ∆/∆ large pre-B cells and not in other BM cells (Supplementary Fig. 5b and data not shown). Treatment with the FAK inhibitor had little effect on the cellularity of wild-type BM B cells, which consisted mainly of small pre-B cells and immature B cells (Fig. 6c) . Given the small number of wild-type large pre-B cells present in wild-type BM, it was difficult to discern the effect of treatment with the FAK inhibitor on the wild-type large pre-B cell population. Together these studies indicated that increased integrin signaling mediated by FAK was responsible for the enhanced stromal adhesion, survival and accumulation of Ikaros-mutant large pre-B cells in both in vitro settings and in vivo settings.
Integrin and growth factor signaling cooperate in pre-B cells
We next assessed whether integrin-mediated adhesion was sufficient to support the stroma-dependent survival and proliferation of IkE5 ∆/∆ pre-B cells. Most IkE5 ∆/∆ pre-B cells plated on fibronectin and collagen died after overnight incubation (Fig. 7a) , which indicated that integrin signaling alone was unable to support their survival. In contrast, most wild-type pre-B cells survived under those conditions (Fig. 7a) .
Stromal niches provide adhesion and growth-factor support. Growth factors such as SCF (the ligand for the receptor CD117 (c-Kit)) and IL-7 are required for the growth of both early hematopoietic progenitors and lymphoid precursors 39, 40 . In the absence of the binding of integrin ligands, IL-7 and/or SCF had little or no effect on the survival of IkE5 ∆/∆ pre-B cells (Fig. 7a,b) . However, the combination of integrin engagement plus either IL-7 or SCF greatly enhanced the survival of IkE5 ∆/∆ pre-B cells (Fig. 7a,b) and had a smaller but still significant stimulatory effect on the proliferation of IkE5 ∆/∆ pre-B cells (Fig. 7c) . Thus, the augmentation of integrin signaling in IkE5 ∆/∆ pre-B cells relative to that in wild-type pre-B cells was important not only for maintaining cells in proximity to a stromal niche but also for cooperation with growth factor signaling to support survival and proliferation, acting in place of pre-BCR signaling (Supplementary Fig. 6 ).
High leukemogenic potential of IkE5 ∆/∆ pre-B cells
The rapid development of precursor T lymphoid neoplasms in IkE5 fl/fl Cd2-Cre mice 41 (data not shown) precluded the assessment of B lymphoid leukemogenesis in these mutant mice. We therefore evaluated the leukemogenic potential of IkE5 ∆/∆ pre-B cells by transplanting that population into immunodeficient recipient mice of the nonobese diabetic-severe combined immunodeficiency strain that were deficient in the common γ-chain (NSG mice). After transplantation of IkE5 ∆/∆ pre-B cells isolated from IkE5 fl/fl Cd2-Cre or IkE5 fl/fl Cd19-Cre donors, recipient NSG mice uniformly exhibited circulating immature CD19 + BP1 + CD2 − B lymphoid cells within 7 weeks (data not shown) and developed signs of disseminated leukemia-lymphoma by 3-4 months after transplantation, along with weight loss, hyperventilation and hepatosplenomegaly (spleen weight, 668 ± 188 mg (mean ± s.e.m.)), whereas recipients of wild-type pre-B cells remained healthy (Fig. 8a) . Histopathology analysis of tissues from the mice described above showed extensive invasion of the spleen and liver and involvement of the BM with large lymphoblasts with immature nuclei and prominent nucleoli, moderate basophilic cytoplasm and a high mitotic index (Fig. 8b) . Phenotypic analysis of the malignant IkE5 ∆/∆ tumor cells revealed that they were similar to the initially transplanted population in terms of surface expression of antigens characteristic of large pre-B cells (CD19 + CD43 + BP1 + CD2 − ; Supplementary Fig. 7a) , expression of adhesion molecules (Fig. 8c) and adherence to stroma (Fig. 8e) . However, in contrast to the polyclonal nature of the transplanted IkE5 ∆/∆ pre-B cell population (Fig. 1g and Supplementary  Fig. 7b) , the IkE5 ∆/∆ leukemic cells were oligoclonal by Igh rearrangement (Supplementary Fig. 7c,d) .
Given that the stroma-adhesion phenotype was maintained in IkE5 ∆/∆ leukemic pre-B cells, we assessed the status of integrin signaling and whether these cells were sensitive to inhibition of FAK in vitro. Both integrin expression and activation of FAK were greater in the IkE5 ∆/∆ leukemic cells than in wild-type pre-B cells (Fig. 8c,d) . Similar to the preleukemic mutant pre-B cells, leukemic IkE5 ∆/∆ pre-B cells were highly sensitive to inhibition of FAK and underwent both loss of adhesion and a substantial increase in apoptosis (Fig. 8e,f) that correlated with suppression of phosphorylated FAK (Fig. 8d) . Thus, the arrest at the adherent large pre-B cell stage mediated by loss of Ikaros predisposed this population for transformation to a leukemic state that, however, seemed to be sensitive to the inhibition of adhesion- npg DISCUSSION Our studies have defined a key step in the differentiation of pre-B cells characterized by adherence to BM stroma, self-renewal and proliferative expansion 36 . Normal pre-B cells transited rapidly through that stroma-adherent phase and entered into a nonadherent phase during which self-renewal was lost, proliferation was diminished and differentiation into cells expressing immunoglobulin κ-chain was induced. Loss of Ikaros activity arrested pre-B cells in the adherent, self-renewing, pro-proliferative phase and promoted their transformation into a malignant state. Ikaros-deficient large pre-B cells had higher expression of structural and signaling components of the focal adhesion and actin cytoskeleton pathways at the level of both transcription and protein. These included genes encoding integrins (Itgb1, Itgb3, Itga9 and Itga5), vinculin (Vcl), α-actinin (Actn1), myosin proteins (Myo1b and Myl12b), FAK (Ptk2), Rac-activating Rho guanine-exchange factors (Arhgef12 and Arhgef5), a Rho GTPase-activating protein (Arhgap5) and a Rac-activating guanine-exchange factor (Dock1). Expression of genes encoding components of the extracellular matrix, such as laminin (Lamb1), a secreted phosphorylated protein (Spp1) and a matrix metallopeptidase (Mmp14), were also induced in mutant pre-B cells. Those transcriptional changes indicated an increase in the potential for integrin signaling that was confirmed by the abundant activated FAK and by the phenotype of stable adhesion and readhesion to both stroma and integrin ligands. Wild-type pre-B cells also demonstrated integrin-dependent adhesion; however, this was transient, as most of the adherent cells rapidly switched to a nonadherent phase and failed to readhere after being replated.
Integrins, which are engaged by the extracellular matrix, serve as signaling centers that control actin filament polymerization required for the formation and maturation of focal adhesions 42, 43 . Published studies have suggested that actin also has a role in organizing adhesion sites, and the actin-integrin linkage composition can determine adhesion stability 44, 45 . Cells that lack highly bundled actin structures, such as lymphocytes, have less prominent adhesions 46 . Expression of the actin crosslinker α-actinin, required for the formation of actin filaments 47 , was upregulated in Ikaros-deficient pre-B cells. Actin polymerization and disassembly are regulated by the opposing activities of the Rho and Rac small GTPases 48 . A potential increase in the Rac-activating guanine-exchange factor Dock1 in Ikaros-deficient pre-B cells may contribute to the establishment of an actin environment that is conducive to integrin signaling. Given the low concentration of Ca 2+ in adherent pre-B cells, the recycling of adhesion structures, such as through the cleavage of talin by calpain, may be ineffective. Consistent with a stable focal adhesion environment, Ikaros-deficient pre-B cells failed to undergo CXCL12-mediated chemotaxis despite normal or elevated expression of CXCR4 and did not exit the BM microenvironment. In this context, a published study has reported increased chemotaxis of FAK-deficient precursors of pre-B cells from the BM to the periphery 49 that is consistent with our observations here of increased FAK activity in Ikaros-deficient pre-B cells and their inability to migrate from the BM to the periphery.
Notably, in wild-type pre-B cells, the pro-proliferative and differentiation-inducing arms of pre-BCR signaling were segregated from each other and into the stroma-adherent and nonadherent phases of pre-B cell differentiation. The presence of IL-7R and the pre-BCR together with active Erk1-Erk2 MAPK and PI(3)K-Akt pathways in wild-type adherent pre-B cells indicated that receptor signaling was actively contributing to survival and proliferation. As wild-type pre-B cells detached from stroma, they rapidly turned off signaling via Erk1-Erk2 and Akt, although expression of the pre-BCR and IL-7R persisted. We observed an increase in the MAPK p38, BLNK and intracellular Ca 2+ , together with a transcriptional induction of pre-B cell differentiation markers. A working model supported by our findings is that in addition to signaling via the pre-BCR and IL-7R, integrin-mediated adhesion and FAK signaling contribute to the proliferative expansion of early pre-B cells and provide limited self-renewal by keeping the cells engaged on stroma. Another important effect of integrin signaling is to shut down the differentiationinducing pathways in pre-B cells either directly or indirectly by promoting proliferation. As adhesion is lost, possibly due to recycling of focal adhesions, the negative effects on differentiation signaling are diminished. An increase in FAK activity has been linked to the pathogenesis of various cancers through the engagement of proproliferative signaling. Increased signaling via integrins and FAK, as in Ikaros-deficient pre-B cells, may be responsible for augmenting self-renewal and proliferation and for further repressing differentiation at this critical developmental stage. A published study has shown that loss of FAK during B cell differentiation results in a lower abundance of pre-B cells and immature B cells 49 and is consistent with the model of integrin signaling in pre-B cell differentiation proposed above.
While integrin-mediated adhesion and activation of the downstream signaling effector FAK were augmented in Ikaros-deficient pre-B cells, those cells had a lower abundance of all pre-BCR-affiliated tyrosine kinases. As transcription of those tyrosine kinases was relatively unperturbed, that effect was probably a consequence of altered protein stability. Feedback mechanisms originating from hyperactive FAK or MAPKs may stimulate the degradation of those effectors of pre-BCR signaling, thereby limiting the number of pro-proliferative signaling pathways operating in mutant pre-B cells. Notably, loss of proximal pre-BCR signaling would not affect the proliferation of pre-B cells, as this is also supported by other receptor signaling pathways, such as growth factor receptors and integrins, but would inhibit differentiation, which is solely dependent on the pre-BCR complex.
The switch from the pre-BCR-IL-7R signaling axis in normal pre-B cells to a more 'progenitor-like' integrin-growth factor signaling paradigm would support the survival and proliferative expansion of Ikaros-deficient pre-B cells. In fact, mutant pre-B cells cycled more rapidly, possibly due to a niche-mediated increase in MAPKs and their downstream targets cyclin D2 and CDK6. The ability of Ikaros-deficient pre-B cells to respond to different growth factors also highlights a potential to survive in different microenvironments. Aberrant expansion of mutant pre-B cell populations to a nonphysiological abundance represented the first step in a leukemic transformation process that evolved rapidly when the Ikarosdeficient pre-B cells were adoptively transferred into an immunocomupromised BM environment. However, the finding that the malignant precursor B-ALL that developed was oligoclonal in terms of Igh rearrangement suggested that additional events are necessary for full malignant transformation. Whereas a subset of Igh rearrangements seemed to be shared by leukemias arising in different recipients, this further suggested that some steps toward malignant transformation had occurred in the primary mice. Nonetheless, the Ikaros-deficient leukemic pre-B cell clones retained stroma-adherent properties, and their survival was still dependent on activation of FAK.
The insights provided here into the mechanisms that support normal pre-B cell differentiation and its aberrant manifestations suggest potential new strategies for the therapy of B-ALL that are linked to the underlying biology of the pre-B cell. Humans with Ikaros-mutant B-ALL have an poorer prognosis despite intensive npg A r t i c l e s treatment, which correlates with persistent residual disease following induction chemotherapy 23, 50 . Whereas inhibiting FAK caused the detachment and death of Ikaros-deficient pre-B cells by depriving them of anchorage-dependent survival, it had little effect on wild-type pre-B cells. Hence, those and other pathways activated in Ikaros-deficient pre-B cells may provide additional targets for therapeutic intervention in B-ALL with a poor prognosis.
METHODS
Methods and any associated references are available in the online version of the paper. Flow cytometry and cell sorting. BM cells were isolated as described 51 . BM cells were harvested from femurs and tibias, followed by lysis of red blood cells with ACK buffer (0.15 M ammonium chloride, 10 mM potassium bicarbonate and 0.1 mM EDTA). For isolation of large pre-B cells, BM samples were depleted of cells binding to anti-Ter119, anti-Mac-1, anti-Gr-1, anti-IgM, anti-CD3, anti-CD8α, anti-TCRβ and anti-DX5 (all antibodies identified above) by removal with magnetic beads conjugated to BioMag goat anti-rat IgG (310107; Qiagen). The cells remaining after depletion were labeled with fluorochrome-conjugated monoclonal antibodies to B cell markers (anti-CD19 (25-0193; eBiosciences), anti-CD43 (553270; BD), anti-BP1 (11-5995; Ebiosciences), anti-CD25 (553075; BD) and anti-CD2 (553112; BD)) for phenotypic analysis, and CD19 + CD43 + BP1 + cells were sorted as large-pre B cells for in vitro culture and high-throughput sequencing of cDNA (RNA-Seq analysis), and CD19 + CD43 − CD25 + cells were sorted as small pre-B cells. The BP1 + fraction of the CD19 + CD43 + population of both wild-type and IkE5 ∆/∆ pre-B cells had lower expression of c-Kit than did pro-B cells. For analysis of immature IgM + cells, BM cells that had not undergone depletion were stained with monoclonal antibody to CD19 (25-0193; eBiosciences) and monoclonal antibody to IgM (552867; BD) and were analyzed in the lymphoid population by electronic gating based on size and granularity. For analysis of integrins by flow cytometry, cells were stained with either phycoerythrin-conjugated antibody anti-α 5 and phycoerythrin-anti-α 6 (both identified above) or primary antibody followed by phycoerythrin-conjugated secondary antibody (8887; Cell Signaling Technology). Antibody to FAK phosphorylated at Tyr925 (3284; Cell Signaling Technology) was used for flow cytometry. A two-laser FACSCanto (BD) or a three-laser MoFlo (Dako Cytomation) was used for flow cytometry. Cells were sorted with a three-laser MoFlo. The resulting files were uploaded to FlowJo (Tree Star) for further analysis. Immunoglobulin gene-rearrangement analysis. DNA was isolated from sorted large pre-B cells and rearrangements of genes encoding the immunoglobulin heavy and light chains were assessed by PCR with primers specific for D-J and V-DJ or V-J rearrangements as described 52, 53 . For D-J H rearrangement, the D H sense primer was used with a J H 3 antisense primer. V-DJ rearrangements were evaluated with a mixture of three different degenerate (at three positions) oligonucleotides homologous to sequences in the conserved framework region 3 of the appropriate V H gene families and the J H 3 antisense primer. For PCR, serial dilutions (1× and 1:3) of the samples were heated to 94 °C for 5 min, followed by amplification with 35 cycles of 1 min at 94 °C, 1 min at 60 °C, and 1 min 30 s at 72 °C. After the final cycle, a final extension step at 72 °C for 10 min was done. PCR products were separated by electrophoresis through 1% agarose gels, then were transferred to membranes and hybridized with probe upstream of the J H 3 primer region. For analysis of V-J rearrangement of the gene encoding immunoglobulin κ-chain, samples were amplified by PCR with a V κ sense primer mixture that is degenerate at four positions and J κ 5 antisense oligonucleotide. Southern blot hybridization of PCR products for V-J rearrangement was done with probes that bind upstream of the J κ 5 region.
ONLINE METHODS
Mice
Stroma-free cultures. Differentiation in stroma-free cultures was done as described 54 . Sorted large pre-B cells (2 × 10 3 ) were plated for 4 d in opti-MEM medium (Gibco) supplemented with 10% FCS, 50 µM 2-mercaptoethanol, 2.4 g/l NaHCO 3 , 100 µg/ml penicillin, 100 µg/ml streptomycin and 5 ng/ml of IL-7 (Peprotech). At day 4, cells were washed and replated in opti-MEM with 2% FCS and 0.05 ng/ml IL-7. After 3 d, cells were harvested and counted and then stained with anti-CD19 (561738; BD), anti-BP1 (11-5995; eBiosciences), anti-IgM (552867; BD) and anti-CD2 (553112; BD) for analysis of cell-surface expression. For analysis of survival and proliferation, large pre-B cells were cultured for 1-3 d without stroma in 0.05-5 ng/ml of IL-7. Cells were harvested and counted and analyzed for cell cycle and apoptosis.
Stromal cultures. Sorted wild-type and IkE5 ∆/∆ large pre-B cells were cultured on OP9 stroma in DMEM ( D-5671; Sigma) supplemented with 10% FBS (2442; Sigma), 50 µM 2-mercaptoethanol, 100 µg/ml penicillin, 100 µg/ml streptomycin, 1× Glutamax (35050-062; Gibco), 10 mM HEPES (156-30-80; Gibco) and 1× sodium pyruvate (11360-070; Gibco) in the presence of various amounts of IL-7 as described 51 . Equal numbers of wild-type pre-B cells and IkE5 ∆/∆ pre-B cells plated in presence of IL-7 were harvested at various time points for counts and analysis of cell cycle, proliferation and apoptosis. All analysis of cultured large pre-B cells was done after removal of the green fluorescent protein-expressing OP9 cells by flow cytometry. Exclusion by electronic gating based on size and granularity was done.
For calculation of the ratio pf adherent cells to nonadherent celss, 5 × 10 4 cells were plated for 1-3 d on stroma in 0.05-5 ng/ml of IL-7. The nonadherent cells were harvested, followed by a wash in PBS. The adherent cells were detached with limited trypsinization treatment. Cells from each fraction were counted under a bright-field microscope and ratios were calculated. For readhesion assays, equal numbers of adherent wild-type cells and IkE5 ∆/∆ cells were allowed to re-attach onto stroma and at 3 h, cells were counted as described above.
Limiting-dilution analysis. Adherent wild-type and IkE5 ∆/∆ adherent large pre-B cells were sorted on stroma in a 96-well plate in stepwise threefold serial limiting dilution (ten replicates per dilution) from 300 cells to 1 cell, with 0-5 ng/ml of IL-7. Colonies were assigned scores after 6 d, by visual inspection. The mean frequency of colony forming cells was calculated with L-Calc software (Stem Cell Technologies) based on Poisson distribution of the probability of wells with a positive score.
Measurement of intracellular calcium and flux.
For measurement of intracellular calcium, nonadherent and adherent wild-type and IkE5 ∆/∆ pre-B cells npg were stained with Fura Red according to the manufacturer's protocol (Life Technologies). For analysis of calcium flux, cells were harvested into staining buffer that contained 25 mM HEPES, pH 7.2, 125 mM NaCl, 5 mM KCl, 1 mM Na 2 HPO 4 , 0.1% glucose, 0.5 mM MgCl 2, 1 mM CaCl 2 and 0.1 g BSA just before use. Calcium Green (Life technologies) and Fura Red were added for 30 min at 37 °C. Cells were washed twice and then resuspended in staining buffer and placed on ice. Just before analysis on a FACSCanto (BD), the cells were equilibrated to 37 °C. Data were acquired for 30 s, followed by a pulse with anti-IgM (11/41; BD) or ionomycin and acquisition for various additional time points. Data were analyzed with the kinetics platform of FlowJo software (Tree Star).
Apoptosis assay. Cells were stained for apoptosis with an Annexin V: Apoptosis Detection Kit I according to the manufacturer's protocol (BD).
Cell-cycle analysis. Cells were harvested at various time points and were fixed overnight at 4 °C in cold 70% ethanol. Fixed cells were stained for 30 min at 37 °C with propidium iodide staining buffer (250 µg/ml RNase A and 50 µg/ml propidium iodide), and the DNA content was detected with a FACSCanto. The resulting files were analyzed with FlowJo software (Tree Star).
BrdU pulse-chase assay. Cells were labeled for 45 min with BrdU (5-bromodeoxyuridine), then were washed and then incubated in growth medium for up to 48 h. Cells were harvested at various time points for proliferation analysis with a BrdU Flow Kit according to the manufacturer's protocol (BD).
Phase-contrast microscopy. Phase-contrast images of large pre-B cells were obtained with a Zeiss Axiovert 200M microscope. Prior to microscopy, cells were cultured for 24 h on green fluorescent protein-expressing OP9 cells in 5 ng/ml of IL-7.
Immunoblot analysis. Cells were harvested and then whole-cell extracts were prepared with radioimmunoprecipitation buffer containing 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS and 140 mM NaCl. Inhibitors of proteases and phosphatases (Roche) were added to the extraction buffer just before use. Equal amounts of protein lysates were separated by SDS-PAGE and transferred to PVDF membranes (Millipore) and probed with antibodies to phosphorylated and total proteins: anti-Akt, anti-Erk, anti-p38, anti-STAT5, anti-Lyn, anti-Syk, anti-FAK, anti-Foxo1, anti-Fyn, anti-BLNK, anti-Btk, anti-cyclin D2, anti-β-tubulin and anti-Blk (all identified above) according to each antibody manufacturer's protocol.
Immunofluorescence. Cells grown on stroma on Lab-Tek Chamber Slides (Electron Microscopy Sciences) were fixed for 20 min at room temperature with 3% paraformaldehyde and then permeabilized for 45 min with 0.1% Tween-20 in PBS. After nonspecific binding was blocked for 10 min with PBS containing 2% BSA, the cells were stained for 45 min with antibody to phosphorylated FAK (identified above), followed by incubation for 30 min with tetramethylrhodamine isothiocyanate-conjugated secondary antibody (A16109; Life Technologies). Slides were treated with Vectashield containing DAPI (4,6-diamidino-2-phenylindole; Vector Laboratories) and mounted. Images were collected with a Nikon A1SiR confocal microscope and were processed with NIS Element confocal imaging software.
Adhesion to integrin ligands and in vitro FAK-inhibition assay. Non-tissueculture-treated plates (BD) were used for adhesion assay. Plates were coated overnight at 4 °C with 10 µg/ml fibronectin and collagen (Invitrogen) or BSA alone. After nonspecific binding on the plates was blocked for 1 h with 2% BSA, equal numbers of cells were plated, followed by incubation for various times. At the end of the assay, unbound and bound cells were harvested and counted. The frequency of adhesion was calculated as the ratio of bound cells to total cells used in assay.
For inhibition assays, 1 µm FAK inhibitor (PF-431396 or PF-562271; Sigma) or DMSO (dimethyl sulfoxide) control was used for treatment, and cells were harvested as bound and unbound fractions at 4 or 24 h after treatment for calculation of the frequency of adhesion and inhibition of adhesion, as well as analysis of apoptosis and cell cycle. For peptide-mediated blocking of adhesion 55 , equal number of cells were pretreated for 45 min with 400 µg/ml Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) or the control peptide Gly-ArgGly-Glu-Ser (GRGES) (American Peptide Company) and then were plated on fibronectin-coated TC dishes. Cells were counted for calculation of the frequency of adhesion and inhibition.
For evaluation of the effect of growth factors and adhesion, 2 × 10 5 adherent pre-B cells were plated for 24 h on plates coated with fibronectin and collagen or with BSA, in the presence of no cytokines or 5 ng/ml IL-7 or 100 ng/ml SCF or both. At 24 h, cells were counted, and cell cycle and apoptosis were analyzed.
In vivo FAK inhibition assay. Wild-type and IkE5 fl/fl Cd19-Cre mice were treated with the FAK inhibitor PF-562271 or vehicle (50% DMSO and 50% PEG-400). Each cohorts was given a dose of 25 mg per kg body weight per mouse of inhibitor or equal volume of vehicle by oral gavage. Dosage regimens of either three or five doses were given at ~12 h apart. At 3 h after the final dose, mice were asphyxiated with CO 2 . BM was flushed and cells were collected and total BM cellularity was estimated. Cells were stained for pre-B cell surface markers with anti-CD19 (25-0193; eBiosciences), anti-CD43 (553270; BD) and anti-BP1 (11-5995; eBiosciences), and propidium iodide-annexin V staining was used for estimation of the frequency of apoptotic cells.
Transwell migration assay. Transwell plates (3422; Corning) were coated with fibronectin (10 µg/ml). The wells were washed and nonospecific binding was blocked with BSA. Serum-free medium with 1% BSA containing CXCL12 (SDF-1α; 100 ng/ml) was added to the bottom well of the Transwell plate. Equal number of cells in 100 µl of serum-free medium were added to the upper chambers, followed by incubation for 2 h at 37 °C. At the end of the time point, the insert was removed and cells that had migrated to the bottom well were counted. Frequency of migration was calculated as the ratio of migrated cells to total cells plated in the insert.
RNA-seq, gene-expression and pathway analysis. RNA isolated with TRIzol was purified with a PureLink RNA Mini kit (Ambion). A Truseq RNA sample prep kit (Illumina) was used for construction of cDNA libraries for RNA-Seq. The cDNA libraries were ligated with indexed primers, followed amplification with 15 cycles of PCR. The amplified libraries were multiplexed and sequenced by the Genome Analyzer at Systems Biology Lab, Harvard University. Read alignment on the mm9 National Center for Biotechnology Information assembly of the mouse genome was done with the Burrows-Wheeler alignment algorithm implemented by the DNA Nexus suite. The easyRNAseq and Deseq algorithms implemented by the R platform were used for counting and normalizing reads per gene coding region and for determining differences in gene expression in freshly sorted wild-type and IkE5 ∆/∆ large pre-B cells and wild-type small pre-B cells, as well as in adherent and nonadherent fractions of sorted large pre-B cells after limited propagation on OP9 stroma. Ingenuity software was used for pathway analysis of genes upregulated in IkE5 ∆/∆ large pre-B cells relative to their expression in wild-type large pre-B cells. Heat maps of normalized tags for gene subsets across wild-type and IkE5 ∆/∆ pre-B cell populations were generated with Avadis software.
Adoptive transfer of purified pre-B cell populations into NSG mice. NSG mice (Jackson Laboratory) were conditioned by gamma irradiation (300 cGy), followed by injection of with 3 × 10 6 sorted large (CD19 + CD43 + BP1 + ) pre-B cells via the lateral tail vein. Diseased mice were characterized by histopathological analysis as described 56 .
